BOTOX (Allergan, Inc.)
Welcome to the PulseAid listing for the BOTOX drug offered from Allergan, Inc.. This Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | onabotulinumtoxinA |
| SUBSTANCE NAME: | BOTULINUM TOXIN TYPE A |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |
| ROUTE: | INTRADERMAL; INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1989-12-15 |
| END MARKETING DATE: | 0000-00-00 |
BOTOX HUMAN PRESCRIPTION DRUG Details:
| Item Description | BOTOX from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100([USP’U]/1) |
| START MARKETING DATE: | 1989-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-1145_e3d7b38d-cd47-4c2f-8808-e298499a7ba8 |
| PRODUCT NDC: | 0023-1145 |
| APPLICATION NUMBER: | BLA103000 |
Other BOTULINUM TOXIN TYPE A Pharmaceutical Manufacturers / Labelers:
